Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance


Celik G. E., Erkekol F., BAVBEK S., Dursun B., Misirligil Z.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.95, no.1, pp.33-37, 2005 (SCI-Expanded) identifier identifier identifier

Abstract

Background: Cyclooxygenase-2 (COX-2) inhibitors are reported to be well tolerated in patients with analgesic intolerance (AI). However, limited data are available about the long-term tolerability of these drugs.